CORTNEY BLACK: Open Payments
NPI 1225481369 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 85 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $469 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $258 |
| ABBVIE INC. | 17 | $173 |
| GlaxoSmithKline, LLC. | 14 | $172 |
| Corium, LLC | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| PFIZER INC. | 4 | $76 |
| Antares Pharma, Inc. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
Products named: TRELEGY ELLIPTA, Ozempic, VRAYLAR, Azstarys, Wegovy, Auvelity, REXULTI, XYOSTED.
Industry payments across AL — which companies pay providers there.
